University of Chicago Medicine Recognized for Community Engagement
AAMC says U. of Chicago Medicine and Pritzker School of Medicine embed community engagement into every aspect of medical education, research, and clinical care
Read More
As Medicaid Unwinding Concludes in Most States, KFF Finds 25 Million Lost Medicaid Coverage but Enrollment is 10 Million Higher Than Pre-Pandemic Levels
Over 25 million people were disenrolled from Medicaid and over 56 million had their coverage renewed, according to KFF’s analysis of the outcomes of the Medicaid unwinding, which nearly all states have now completed.
An Examination of Medicaid Renewal Outcomes and Enrollment Changes at the End of the Unwinding
Using data from the KFF Medicaid Enrollment and Unwinding Tracker, this analysis reports data on unwinding renewal outcomes through June 2024 and examines Medicaid enrollment changes from February 2020 through May 2024, the most recent federal enrollment data available, nationally and across states.
Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary
By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024. The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.
Bringing PREMs and PROMs Into Value-Based Care
CMS Innovation Center leading the way on including patient-reported measures in payment models
CommonWell: Addition of Labcorp Is Spurring FHIR Adoption
Labcorp’s addition to the network has become a driver for deploying FHIR data exchange at scale for testing among members
Unpacking the FDA’s Non-Recall Recalls
When the Agriculture Department posted a recall of chicken nuggets that might be contaminated, it directed consumers to return them or throw the stuff away. When the Consumer Product Safety Commission announced that poorly designed baby loungers could suffocate babies, it warned consumers to immediately stop using them. But when it comes to medical devices,…
Effective diagnostic processes and patient safety means not having to ask “What if”
“What If” I was seen, heard, and treated like a partner? Regarded as the greatest English novelist during the Victorian Era, Charles Dickens once said, “It was the best of times, it was the worst of times, it was the age of wisdom, it was the age of foolishness.” Those words never rang truer than…
Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack
While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events. The post Millions are Taking a Drug that Falls Short of…
The FDA Isn’t Blocking Medical Breakthroughs — Our Outdated Innovation Model Is
The current model of siloed, proprietary development is failing us. It’s slow, expensive, and often results in technologies that never see the light of day. What if, instead, we embraced an open-source approach to medical device innovation? The post The FDA Isn’t Blocking Medical Breakthroughs — Our Outdated Innovation Model Is appeared first on MedCity…